Immunohistochemistry in Lung Cancer Immunohistochemistry represents an important complementary tool for the routine diagnosis of lung cancer and for the identification of the different histological types and prognostic factors. Its purpose is to categorize patients in order to ensure appropriate and specific ...
2015. Programmed death-ligand 1 immunohistochemistry in lung cancer: in what state is this art? J. Thorac.Oncol. 10:985-989.Kerr, K. M., M.-S. Tsao, A. G. Nicholson, Y. Yatabe, I. I. Wistuba, and F. R. Hirsch. 2015. Programmed death-ligand 1 immunohistochemistry in lung...
- 《Journal of Thoracic Oncology Official Publication of the International Association for the Study of Lung Cancer》 被引量: 0发表: 2015年 Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer In what state is this art? Programmed death-ligand 1 immunohistochemistry in lung cancer: in ...
Immunohistochemistry in the Differential Diagnostics of Primary Lung Cancer: An Investigation Within the Southern Swedish Lung Cancer Study Brunnstrom H, Johansson L, Jirstrom K, Jonsson M, Jonsson P and Planck M: Immunohistochemistry in the differential diagnostics of primary lung cancer: An... H ...
Immunohistochemistry and in situ hybridisation in the diagnosis and prognosis of lung cancer 来自 Semantic Scholar 喜欢 0 阅读量: 15 作者:Sheppard,N Mary 摘要: It is therefore apparent that great use has been made of the multiple antibodies available in the diagnosis of lung tumours. Their role...
Moreover, we discuss the opportunity to provide accredited IHC tests in the context of stratified medicine for lung cancer patients. 展开 关键词: accreditation immunohistochemistry lung cancer molecular biology personalized medicine targeted therapy
AIM: To investigate the expression of ALDH1A2, E-cadherin and MMP2 in colonic cancer and to analyze their clinical significance. METHODS: RT-PCR, Western blot and immunohistochemistry were used to examine the expression and distribution of ALDH1A2, E-cadherin and MMP2 in 52 surgically resected...
Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay Mutations in the epidermal growth factor receptor (EGFR) gene have been reported to be present in non-small cell lung cancer (NSCLC) and related to the res... Asano,H. - 《Clinical Cancer Resear...
Xu H, Lin G, Huang C, Zhu W, Miao Q, Fan X, Wu B, Zheng X, Lin X, Jiang K, Hu D, Li C. Assessment of concordance between 22C3 and SP142 immunohistochemistry assays regarding PD-L1 expression in non-small cell lung cancer. Sci Rep 2017;7:16956- 7034....
Combined use of immunohistochemistry and in situ hybridization for chromogranin A to detect small cell lung cancer with neuroendocrine features - Lung Cancerdoi:10.1016/0169-5002(94)93858-XNoneLung Cancer